Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The effects of aflibercept on the viability and metabolism of ocular cells in vitro.

Ammar DA, Mandava N, Kahook MY.

Retina. 2013 May;33(5):1056-61. doi: 10.1097/IAE.0b013e31827b646d.

PMID:
23266881
[PubMed - indexed for MEDLINE]
2.

In vitro effects of verteporfin on ocular cells.

Ammar DA, Kahook MY.

Mol Vis. 2013;19:424-9. Epub 2013 Feb 20.

PMID:
23441114
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture.

Malik D, Tarek M, Caceres del Carpio J, Ramirez C, Boyer D, Kenney MC, Kuppermann BD.

Br J Ophthalmol. 2014 Jun;98 Suppl 1:i11-16. doi: 10.1136/bjophthalmol-2014-305302.

PMID:
24836865
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells.

Schnichels S, Hagemann U, Januschowski K, Hofmann J, Bartz-Schmidt KU, Szurman P, Spitzer MS, Aisenbrey S.

Br J Ophthalmol. 2013 Jul;97(7):917-23. doi: 10.1136/bjophthalmol-2013-303130. Epub 2013 May 17.

PMID:
23686000
[PubMed - indexed for MEDLINE]
5.

Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.

Deissler HL, Lang GK, Lang GE.

Exp Eye Res. 2014 May;122:20-31. doi: 10.1016/j.exer.2014.02.024. Epub 2014 Mar 11.

PMID:
24631334
[PubMed - indexed for MEDLINE]
Free Article
6.

In vitro effects of antivascular endothelial growth factors on cultured human trabecular meshwork cells.

Kahook MY, Ammar DA.

J Glaucoma. 2010 Sep;19(7):437-41. doi: 10.1097/IJG.0b013e3181ca74de.

PMID:
20164801
[PubMed - indexed for MEDLINE]
7.

Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes.

Julien S, Biesemeier A, Taubitz T, Schraermeyer U.

Br J Ophthalmol. 2014 Jun;98(6):813-25. doi: 10.1136/bjophthalmol-2013-304019. Epub 2014 Jan 23.

PMID:
24457369
[PubMed - indexed for MEDLINE]
8.

Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).

Ayalasomayajula SP, Ashton P, Kompella UB.

J Ocul Pharmacol Ther. 2009 Apr;25(2):97-103. doi: 10.1089/jop.2008.0090.

PMID:
19284324
[PubMed - indexed for MEDLINE]
9.

Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.

Kernt M, Thiele S, Neubauer AS, Koenig S, Hirneiss C, Haritoglou C, Ulbig MW, Kampik A.

Retina. 2012 Sep;32(8):1652-63. doi: 10.1097/IAE.0b013e318240a558.

PMID:
22466477
[PubMed - indexed for MEDLINE]
10.

[Multikinase inhibitors as a new approach in neovascular age-related macular degeneration (AMD) treatment: in vitro safety evaluations of axitinib, pazopanib and sorafenib for intraocular use].

Thiele S, Liegl RG, König S, Siedlecki J, Langer J, Eibl K, Haritoglou C, Kampik A, Kernt M.

Klin Monbl Augenheilkd. 2013 Mar;230(3):247-54. doi: 10.1055/s-0032-1328161. Epub 2013 Mar 18. German.

PMID:
23508753
[PubMed - indexed for MEDLINE]
11.

Intracameral moxifloxacin: in vitro safety on human ocular cells.

Kernt M, Neubauer AS, Liegl RG, Lackerbauer CA, Eibl KH, Alge CS, Ulbig MW, A AK.

Cornea. 2009 Jun;28(5):553-61. doi: 10.1097/ICO.0b013e318191447b.

PMID:
19421040
[PubMed - indexed for MEDLINE]
12.

Potential anti-vascular endothelial growth factor therapies for central retinal vein occlusion.

Figueroa MS, Contreras I.

Drugs. 2012 Nov 12;72(16):2063-71. doi: 10.2165/11640820-000000000-00000.

PMID:
23061805
[PubMed - indexed for MEDLINE]
13.

Evaluation of differential toxicity of varying doses of bevacizumab on retinal ganglion cells, retinal pigment epithelial cells, and vascular endothelial growth factor-enriched choroidal endothelial cells.

Brar VS, Sharma RK, Murthy RK, Chalam KV.

J Ocul Pharmacol Ther. 2009 Dec;25(6):507-11. doi: 10.1089/jop.2009.0028.

PMID:
20028259
[PubMed - indexed for MEDLINE]
14.

Aflibercept for age-related macular degeneration: a game-changer or quiet addition?

Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW.

Am J Ophthalmol. 2012 Aug;154(2):222-6. doi: 10.1016/j.ajo.2012.04.020. Review.

PMID:
22813448
[PubMed - indexed for MEDLINE]
15.

Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells.

Spitzer MS, Wallenfels-Thilo B, Sierra A, Yoeruek E, Peters S, Henke-Fahle S, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.

Br J Ophthalmol. 2006 Oct;90(10):1316-21. Epub 2006 May 24.

PMID:
16723358
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intraocular caspofungin: in vitro safety profile for human ocular cells.

Kernt M, Kampik A.

Mycoses. 2011 Jul;54(4):e110-21. doi: 10.1111/j.1439-0507.2009.01853.x. Epub 2010 Feb 19.

PMID:
20202116
[PubMed - indexed for MEDLINE]
17.

Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization.

Puddu A, Sanguineti R, Durante A, Nicolò M, Viviani GL.

Mol Vis. 2012;18:2509-17. Epub 2012 Oct 11.

PMID:
23112566
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione.

Miura Y, Klettner A, Roider J.

Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4848-55. doi: 10.1167/iovs.09-4699. Epub 2010 Apr 30.

PMID:
20435596
[PubMed - indexed for MEDLINE]
Free Article
19.

Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation.

Chen CL, Liang CM, Chen YH, Tai MC, Lu DW, Chen JT.

Acta Ophthalmol. 2012 Aug;90(5):e389-98. doi: 10.1111/j.1755-3768.2012.02426.x. Epub 2012 Jun 19.

PMID:
22712616
[PubMed - indexed for MEDLINE]
20.

Differential effects of nicotine on retinal and vascular cells in vitro.

Patil AJ, Gramajo AL, Sharma A, Seigel GM, Kuppermann BD, Kenney MC.

Toxicology. 2009 May 2;259(1-2):69-76. doi: 10.1016/j.tox.2009.02.004. Epub 2009 Feb 20.

PMID:
19428945
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk